{"id":"loop-diuretic","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Hypokalemia"},{"rate":"5-10","effect":"Hyperuricemia"},{"rate":"1-5","effect":"Ototoxicity (high doses)"},{"rate":"5-10","effect":"Hyperglycemia"},{"rate":"5-15","effect":"Hypotension"},{"rate":"5-10","effect":"Dehydration"},{"rate":"2-5","effect":"Hyponatremia"}]},"_chembl":{"chemblId":"CHEMBL2396767","moleculeType":"Protein","molecularWeight":"4254.99"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By blocking the Na-K-2Cl cotransporter (NKCC2) on the apical membrane of thick ascending limb cells, loop diuretics prevent the reabsorption of up to 25% of filtered sodium and chloride. This results in increased osmotic pressure in the tubular lumen, reducing water reabsorption in the collecting duct and producing potent diuresis. Loop diuretics are the most efficacious diuretic class and are particularly effective in patients with reduced glomerular filtration rate or significant fluid overload.","oneSentence":"Loop diuretics inhibit the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, preventing reabsorption of sodium and chloride and increasing urine output.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:52:53.152Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Edema associated with congestive heart failure"},{"name":"Edema associated with hepatic cirrhosis"},{"name":"Edema associated with renal disease"},{"name":"Hypertension"},{"name":"Pulmonary edema"}]},"trialDetails":[{"nctId":"NCT07369856","phase":"NA","title":"Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2025-11-04","conditions":"Heart Failure, Diuretics","enrollment":300},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT07469722","phase":"PHASE2, PHASE3","title":"POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2026-03-23","conditions":"Acute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect","enrollment":128},{"nctId":"NCT07468344","phase":"NA","title":"Evaluation of the Effects of Sauna Therapy on Congestion and Loop Diuretic Use in Patients With Heart Failure With Reduced or Moderately Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"BAUDRY Guillaume","startDate":"2026-04","conditions":"Heart Failure","enrollment":46},{"nctId":"NCT02627196","phase":"NA","title":"Baroreflex Activation Therapy for Heart Failure","status":"COMPLETED","sponsor":"CVRx, Inc.","startDate":"2016-04-19","conditions":"Heart Failure","enrollment":1090},{"nctId":"NCT06995144","phase":"PHASE4","title":"Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-05-28","conditions":"Heart Failure, Edema, Pulmonary Congestion","enrollment":20},{"nctId":"NCT07223502","phase":"PHASE3","title":"A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease","status":"RECRUITING","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-12-01","conditions":"Hypertension (HTN)","enrollment":30},{"nctId":"NCT07043634","phase":"PHASE3","title":"A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-06-15","conditions":"Bioavailability Heathy Volunteers","enrollment":24},{"nctId":"NCT07372040","phase":"PHASE2","title":"Add-on Diuretics in Acute Decompensated Heart Failure","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"Acute Decompensated Heart Failure","enrollment":66},{"nctId":"NCT03892148","phase":"PHASE4","title":"Protocol of Diuretics Use in Congestive Therapy in Heart Failure","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-05-17","conditions":"Heart Failure, Acute Heart Failure, Chronic Heart Failure","enrollment":299},{"nctId":"NCT07077772","phase":"NA","title":"Natriuresis-guided Depletion After Cardiac Surgery","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-06-25","conditions":"Cardiac Surgery, Diuresis, Congestion, Venous","enrollment":102},{"nctId":"NCT06052163","phase":"PHASE2","title":"Bumetanide in Patients With Alzheimer's Disease","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-04-10","conditions":"Alzheimer Disease","enrollment":40},{"nctId":"NCT07335900","phase":"NA","title":"A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-12-19","conditions":"Severe Aortic Valve Stenosis","enrollment":25},{"nctId":"NCT05898022","phase":"PHASE4","title":"Pragmatic Research on Diuretic Management in Early BPD Pilot","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-08-17","conditions":"Bronchopulmonary Dysplasia","enrollment":19},{"nctId":"NCT07320677","phase":"NA","title":"Finding Heart Failure in Those Prescribed Loop Diuretics in Primary Care in Jersey","status":"ENROLLING_BY_INVITATION","sponsor":"Government of Jersey","startDate":"2025-11-01","conditions":"Heart Failure, Diuretics","enrollment":400},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT06285760","phase":"","title":"Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)","status":"RECRUITING","sponsor":"Puerta de Hierro University Hospital","startDate":"2024-03-01","conditions":"Heart Failure, Persistent Congestion","enrollment":64},{"nctId":"NCT07285187","phase":"","title":"Venous Congestion And Delirium After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative, Venous Congestion, Postoperative Delirium (POD)","enrollment":120},{"nctId":"NCT05171686","phase":"PHASE4","title":"Diuretics and Volume Overload in Early CKD","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2023-02-01","conditions":"Chronic Kidney Disease, Hypertension","enrollment":49},{"nctId":"NCT07110415","phase":"PHASE4","title":"Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction","status":"RECRUITING","sponsor":"SPH Qingdao Growful Pharmacetical Co.,Ltd","startDate":"2025-11-06","conditions":"Coronary Heart Disease, Cardiac Dysfunction","enrollment":2708},{"nctId":"NCT07232277","phase":"","title":"Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-10-15","conditions":"Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury","enrollment":114},{"nctId":"NCT04980716","phase":"PHASE3","title":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-06-01","conditions":"Non-small Cell Lung Cancer, Cardiovascular Complication","enrollment":524},{"nctId":"NCT03296813","phase":"PHASE3","title":"TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-07-11","conditions":"Heart Failure","enrollment":2973},{"nctId":"NCT07199088","phase":"NA","title":"Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure","status":"RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-10-11","conditions":"Acute Decompensated Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic","enrollment":320},{"nctId":"NCT05098665","phase":"NA","title":"PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY","status":"RECRUITING","sponsor":"Richmond Research Institute","startDate":"2025-01-01","conditions":"Cardiac Amyloidosis","enrollment":320},{"nctId":"NCT07076615","phase":"PHASE4","title":"The Effect of Dapagliflozin on Patients With Cardiomyopathy","status":"RECRUITING","sponsor":"May Mohamed Abdalla","startDate":"2025-08","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":100},{"nctId":"NCT02546583","phase":"PHASE1","title":"Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-08-31","conditions":"Heart Failure","enrollment":458},{"nctId":"NCT07099885","phase":"NA","title":"Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2025-08-01","conditions":"Acute Heart Failure (AHF), Congestion, Venous","enrollment":90},{"nctId":"NCT05411991","phase":"PHASE4","title":"Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment","status":"COMPLETED","sponsor":"Vrije Universiteit Brussel","startDate":"2022-06-12","conditions":"Acute Heart Failure, Diuretics Drug Reactions","enrollment":107},{"nctId":"NCT02638142","phase":"","title":"Loop Diuretic Therapy in Acutely Decompensated Heart Failure","status":"RECRUITING","sponsor":"University of Siena","startDate":"2015-12","conditions":"Acute Heart Failure","enrollment":370},{"nctId":"NCT06092437","phase":"NA","title":"Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients","status":"RECRUITING","sponsor":"Zuyderland Medisch Centrum","startDate":"2023-02-27","conditions":"Heart Failure Acute","enrollment":466},{"nctId":"NCT01679132","phase":"NA","title":"BAROSTIM NEO Hypertension Pivotal Trial","status":"SUSPENDED","sponsor":"CVRx, Inc.","startDate":"2013-04-12","conditions":"Uncontrolled Hypertension","enrollment":10},{"nctId":"NCT01471834","phase":"NA","title":"Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"CVRx, Inc.","startDate":"2011-06","conditions":"High Blood Pressure","enrollment":40},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT07008365","phase":"PHASE3","title":"The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria Aragón","startDate":"2025-03-10","conditions":"Acute Heart Failure, Congestive Heart Failure, Intraabdominal Hypertension","enrollment":168},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT05318105","phase":"NA","title":"Ultrafiltration Versus IV Diuretics in Worsening Heart Failure","status":"RECRUITING","sponsor":"Nuwellis, Inc.","startDate":"2022-06-28","conditions":"Heart Failure (for Example, Fluid Overload), Heart Failure, Fluid Overload","enrollment":372},{"nctId":"NCT06362668","phase":"NA","title":"EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)","status":"COMPLETED","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2024-05-17","conditions":"Acute Decompensated Heart Failure","enrollment":12},{"nctId":"NCT06166654","phase":"PHASE4","title":"Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload","status":"RECRUITING","sponsor":"Johannes Grand","startDate":"2024-09-05","conditions":"Acute Heart Failure","enrollment":939},{"nctId":"NCT05652322","phase":"PHASE2, PHASE3","title":"Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Jan Kochanowski University","startDate":"2022-12-07","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT06783166","phase":"PHASE2, PHASE3","title":"Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-08-15","conditions":"Acute Heart Failure","enrollment":100},{"nctId":"NCT05276219","phase":"PHASE4","title":"Optimized Treatment of Pulmonary Edema or Congestion","status":"RECRUITING","sponsor":"Johannes Grand","startDate":"2023-09-14","conditions":"Pulmonary Edema, Congestive Heart Failure, Acute Heart Failure","enrollment":1104},{"nctId":"NCT05129722","phase":"PHASE4","title":"Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial","status":"TERMINATED","sponsor":"The George Institute","startDate":"2022-10-01","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":3},{"nctId":"NCT03302910","phase":"NA","title":"Short Stay Unit vs Hospitalization in Acute Heart Failure","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-12-06","conditions":"Acute Heart Failure","enrollment":194},{"nctId":"NCT03505788","phase":"PHASE4","title":"Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2018-11-11","conditions":"Acute Decompensated Heart Failure, Volume Overload","enrollment":519},{"nctId":"NCT04589065","phase":"NA","title":"SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)","status":"SUSPENDED","sponsor":"Lenar Yessayan","startDate":"2025-09","conditions":"Heart Failure, Chronic Systolic Heart Failure, Renal Failure","enrollment":10},{"nctId":"NCT03259165","phase":"PHASE2","title":"Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial","status":"TERMINATED","sponsor":"Indiana University","startDate":"2017-12-14","conditions":"Heart Failure, Heart Failure Acute, Acute Cardiac Failure","enrollment":52},{"nctId":"NCT05169411","phase":"","title":"Preserving Kidney Function in Children With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-09-22","conditions":"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease","enrollment":20240},{"nctId":"NCT06535529","phase":"PHASE3","title":"Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients","status":"RECRUITING","sponsor":"Helwan University","startDate":"2024-08-24","conditions":"Acute Decompensated Heart Failure","enrollment":60},{"nctId":"NCT06414759","phase":"PHASE4","title":"Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Acute Decompensated Heart Failure, Volume Overload, Edema","enrollment":110},{"nctId":"NCT06510270","phase":"NA","title":"Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Aswan University","startDate":"2024-08-01","conditions":"Heart Failure with Preserved Ejection Fraction","enrollment":70},{"nctId":"NCT05364190","phase":"PHASE3","title":"Canagliflozin in Patients With Acute Decompansted Heart Failure","status":"COMPLETED","sponsor":"October 6 University","startDate":"2022-06-04","conditions":"Chronic Heart Failure, Acute Heart Failure, Diabetes Mellitus","enrollment":142},{"nctId":"NCT03136198","phase":"PHASE2","title":"B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-07-10","conditions":"Heart Failure, Heart Failure Acute, Acute Cardiac Pulmonary Edema","enrollment":130},{"nctId":"NCT06397404","phase":"","title":"VExUS in Patients With Acute Heart Failure","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-05-18","conditions":"Acute Heart Failure","enrollment":100},{"nctId":"NCT04606927","phase":"NA","title":"Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2021-02-01","conditions":"Heart Failure Acute","enrollment":310},{"nctId":"NCT04615624","phase":"PHASE3","title":"Furosemide vs. Placebo for Severe Antepartum Hypertension","status":"COMPLETED","sponsor":"Melanie Maykin, MD","startDate":"2021-01-04","conditions":"Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications","enrollment":65},{"nctId":"NCT04298229","phase":"PHASE3","title":"Efficacy and Safety of Dapagliflozin in Acute Heart Failure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-04-01","conditions":"Heart Failure, Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT04030234","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-09-17","conditions":"Hypertension","enrollment":11255},{"nctId":"NCT06203236","phase":"PHASE4","title":"Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01","conditions":"Acute Heart Failure, Chronic Kidney Diseases","enrollment":300},{"nctId":"NCT05287100","phase":"NA","title":"To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-01-01","conditions":"Cirrhosis, Liver","enrollment":35},{"nctId":"NCT05620784","phase":"PHASE3","title":"Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-03-01","conditions":"BPH With Urinary Obstruction, BPH, Hematuria","enrollment":138},{"nctId":"NCT01474200","phase":"NA","title":"Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment","status":"TERMINATED","sponsor":"Nuwellis, Inc.","startDate":"2012-01","conditions":"Heart Failure, Cardiac Failure, Acute Decompensated Heart Failure (ADHF)","enrollment":224},{"nctId":"NCT05965934","phase":"PHASE1, PHASE2","title":"Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0","status":"UNKNOWN","sponsor":"Sequana Medical N.V.","startDate":"2023-07-07","conditions":"Heart Failure, Volume Overload","enrollment":33},{"nctId":"NCT04354376","phase":"","title":"Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-09-22","conditions":"Hypertension","enrollment":40048},{"nctId":"NCT01275729","phase":"NA","title":"The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2010-12","conditions":"Acute Kidney Failure","enrollment":96},{"nctId":"NCT03740048","phase":"PHASE3","title":"A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-06-19","conditions":"End Stage Renal Failure on Dialysis","enrollment":51},{"nctId":"NCT05840536","phase":"PHASE4","title":"Combination Diuretic Therapy for Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Ochsner Health System","startDate":"2014-05","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT02592499","phase":"NA","title":"Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure","status":"UNKNOWN","sponsor":"Vastra Gotaland Region","startDate":"2016-06","conditions":"End-stage Heart Failure","enrollment":80},{"nctId":"NCT03999216","phase":"PHASE4","title":"Comparing Diuretic Strategies in Hospitalized Heart Failure","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2023-07","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT05087940","phase":"","title":"Treatment of Resistant Hypertension: Cohort Study","status":"COMPLETED","sponsor":"Galenika AD Beograd","startDate":"2021-06-01","conditions":"Resistant Hypertension","enrollment":731},{"nctId":"NCT04778787","phase":"PHASE4","title":"Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2021-01-01","conditions":"Congestive Heart Failure","enrollment":370},{"nctId":"NCT04882358","phase":"NA","title":"Safety & Feasibility of DSR TherApy in Heart FAiluRe pAtients With Persistent Congestion","status":"UNKNOWN","sponsor":"Sequana Medical N.V.","startDate":"2021-05-27","conditions":"Heart Failure, Volume Overload","enrollment":24},{"nctId":"NCT01647932","phase":"PHASE3","title":"Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure","status":"COMPLETED","sponsor":"Spanish Society of Internal Medicine","startDate":"2014-10","conditions":"Heart Failure","enrollment":232},{"nctId":"NCT04331132","phase":"NA","title":"Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction","status":"UNKNOWN","sponsor":"Gia Dinh People Hospital","startDate":"2021-12-01","conditions":"Acute Heart Failure","enrollment":128},{"nctId":"NCT05352633","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-07-18","conditions":"Blood Pressure","enrollment":710},{"nctId":"NCT04622709","phase":"PHASE2","title":"Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-10-07","conditions":"Chronic Kidney Disease Requiring Chronic Dialysis","enrollment":39},{"nctId":"NCT04697485","phase":"PHASE4","title":"Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2021-01-08","conditions":"HF - Heart Failure, Diabetes Mellitus","enrollment":""},{"nctId":"NCT02476409","phase":"PHASE4","title":"Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-07","conditions":"Congestive Heart Failure","enrollment":40},{"nctId":"NCT04235062","phase":"NA","title":"NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure","status":"COMPLETED","sponsor":"Momentum Research, Inc.","startDate":"2020-04-01","conditions":"Heart Failure","enrollment":229},{"nctId":"NCT03187509","phase":"PHASE4","title":"Weight-Based Torsemide Dosing in Subjects With Heart Failure","status":"COMPLETED","sponsor":"New York City Health and Hospitals Corporation","startDate":"2018-04-17","conditions":"Heart Failure","enrollment":52},{"nctId":"NCT04192110","phase":"PHASE4","title":"Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2020-08-11","conditions":"Chronic Kidney Disease","enrollment":""},{"nctId":"NCT05090137","phase":"NA","title":"Quantifying Congestion by Ultrasound","status":"UNKNOWN","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2021-11","conditions":"Heart Failure","enrollment":20},{"nctId":"NCT04572867","phase":"NA","title":"Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Ramona Gelzer Bell","startDate":"2021-06-08","conditions":"Heart Failure, Congestive Heart Failure, Decompensated Heart Failure","enrollment":""},{"nctId":"NCT03226457","phase":"PHASE4","title":"SGLT2 Inhibition in Combination With Diuretics in Heart Failure","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2017-12-11","conditions":"Heart Failure, Type 2 Diabetes Mellitus","enrollment":23},{"nctId":"NCT03071653","phase":"PHASE2","title":"Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study","status":"SUSPENDED","sponsor":"University of Cape Town","startDate":"2016-11-24","conditions":"Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy","enrollment":30},{"nctId":"NCT03161158","phase":"NA","title":"PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure","status":"TERMINATED","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2017-11-03","conditions":"Heart Failure, Acute Heart Failure","enrollment":62},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03484286","phase":"NA","title":"Selfcare Management Intervention in Heart Failure","status":"COMPLETED","sponsor":"Lund University","startDate":"2018-04-03","conditions":"Heart Failure","enrollment":124},{"nctId":"NCT04162444","phase":"","title":"Results of the Aortic Valve Reconstruction in Children","status":"RECRUITING","sponsor":"National Medical Research Center for Children's Health, Russian Federation","startDate":"2020-02-18","conditions":"Aortic Valve Insufficiency","enrollment":40},{"nctId":"NCT03730961","phase":"PHASE2","title":"An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2019-01-17","conditions":"Cardiac Failure, Myocardial Failure, Congestive Heart Failure","enrollment":23},{"nctId":"NCT03574857","phase":"PHASE4","title":"Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2018-06-01","conditions":"Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure Acute","enrollment":5},{"nctId":"NCT03863626","phase":"NA","title":"Exploring Diuretics Effective Management in Acute Decompensated Heart Failure, EDEMA Trial","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-03-31","conditions":"Acute Decompensated Heart Failure, Diuretics Resistance","enrollment":400},{"nctId":"NCT01206062","phase":"NA","title":"Systolic Blood Pressure Intervention Trial","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-10","conditions":"Hypertension","enrollment":9361},{"nctId":"NCT04691687","phase":"PHASE4","title":"OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure","status":"COMPLETED","sponsor":"New York Presbyterian Brooklyn Methodist Hospital","startDate":"2012-05-01","conditions":"Heart Failure","enrollment":100},{"nctId":"NCT04679571","phase":"NA","title":"Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-12-30","conditions":"Decompensated Cirrhosis","enrollment":100},{"nctId":"NCT03056651","phase":"NA","title":"Day-care Unit for Patients With Refractory Heart Failure","status":"UNKNOWN","sponsor":"Silesian Centre for Heart Diseases","startDate":"2016-04","conditions":"Heart Failure, Heart Diseases, Cardiovascular Diseases","enrollment":200},{"nctId":"NCT04163588","phase":"PHASE3","title":"Sequential Nephron Blockade in Acute Heart Failure","status":"UNKNOWN","sponsor":"Policlinico Casilino ASL RMB","startDate":"2019-10-01","conditions":"Acute Heart Failure","enrollment":310},{"nctId":"NCT02606253","phase":"PHASE4","title":"Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2016-02","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT01439009","phase":"PHASE4","title":"Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2011-09","conditions":"Heart Failure","enrollment":100},{"nctId":"NCT02585843","phase":"PHASE2, PHASE3","title":"Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance","status":"COMPLETED","sponsor":"Columbia University","startDate":"2015-11","conditions":"Heart Failure","enrollment":20}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"BLOOD PRESSURE INADEQUATELY CONTROLLED"},{"count":2,"reaction":"HYPERTENSION"},{"count":2,"reaction":"LEFT VENTRICULAR HYPERTROPHY"},{"count":2,"reaction":"PULMONARY EMBOLISM"},{"count":1,"reaction":"ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED"},{"count":1,"reaction":"ANAEMIA"},{"count":1,"reaction":"ANGINA PECTORIS"},{"count":1,"reaction":"ANURIA"},{"count":1,"reaction":"AORTIC ARTERIOSCLEROSIS"},{"count":1,"reaction":"ARTERIAL DISORDER"}],"_approvalHistory":[],"publicationCount":1836,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"loop diuretic","genericName":"loop diuretic","companyName":"The Christ Hospital","companyId":"the-christ-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Loop diuretics inhibit the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, preventing reabsorption of sodium and chloride and increasing urine output. Used for Edema associated with congestive heart failure, Edema associated with hepatic cirrhosis, Edema associated with renal disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}